Pro-Dex
Builds powered surgical handpieces and repair programs for medical-device OEM customers.
Something off on this page? Send us feedback.
Profile
Designs and manufactures powered surgical drivers, shavers, and air motors for medical-device OEMs, then supports them with repairs and prototype work. The business runs as one segment and is shaped by exclusive supply agreements with a highly concentrated customer base.
Designs and manufactures autoclavable battery-powered and electric surgical drivers, shavers, and related handpieces used in orthopedic, thoracic, and craniomaxillofacial procedures. Finished devices sit alongside repair programs, prototype work, and a smaller line of precision air motors.
Works mainly as an OEM and turnkey development partner rather than a broad consumer-facing brand, with machining in Irvine and assembly in Tustin. Patented torque-limiting and sealing technology, plus regulated manufacturing support such as ISO 13485 and FDA registration, help anchor that role.
Sales are concentrated in medical devices and repairs, while legacy industrial air motors and remaining dental components play a minor role. Demand is heavily tied to a small set of customers under exclusive supply agreements, including one customer that accounts for most revenue.
Company facts
Key statistics
Year to date +65.1% · Average volume (30d) 77.5K
Analysts
No analyst consensus on record.
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Apr 30, 2026Q3 FY26 | $0.62 | $1.20 | +93.5% | $17.9M | $19.9M | +11.4% | −3.55% |
| Jan 29, 2026Q2 FY26 | $0.59 | $0.66 | +11.9% | $17.3M | $18.7M | +7.9% | −0.46% |
| Oct 30, 2025Q1 FY26 | $0.50 | $0.62 | +24.0% | $15.3M | $18.5M | +21.1% | +18.32% |
| Sep 4, 2025Q4 FY25 | $0.47 | $0.36 | −23.4% | $15.3M | $17.5M | +14.3% | −16.51% |
Financial highlights
| 12 quarters | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $16.8M | $17.4M | $17.5M | $18.5M | $18.7M | $19.9M | |
| Gross profit | $5.1M | $5.8M | $3.5M | $5.4M | $5.7M | $6.1M | |
| Operating income | $2.7M | $3.6M | $1.3M | $3.1M | $3.3M | $3.1M | |
| Net income | $2.0M | $3.3M | $1.2M | $4.7M | $2.2M | $3.9M | |
| Diluted EPS | $0.61 | $0.98 | $0.36 | $1.40 | $0.66 | $1.20 | |
| Gross margin | 30.2% | 33.3% | 19.9% | 29.0% | 30.8% | 30.7% | |
| Operating margin | 16.0% | 20.9% | 7.7% | 16.8% | 17.5% | 15.5% |
Fiscal years (4-quarter sums)FY21 $38.0M · FY22 $42.0M · FY23 $46.1M · FY24 $53.8M · FY25 $66.6M
Balance sheet, Mar 31, 2026Cash & short-term investments $11.0M · Total debt $20.2M · Total assets $75.0M · Shareholders' equity $45.2M
Dividends
No dividends on record.
Ownership
Shares outstanding 3.19M · Float 1.73M · 54.2% free float
A Form 4 total here can count shares the filer formally disclaims — an award voted by proxy, for instance — which the holder's own Schedule 13D/G excludes, so where the two disagree the schedule's smaller figure is used.
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Swenson Nicholas John | 1.02M | 31.88% | 13D | Jun 26, 2026 |
| Raymond E. Cabillot · director, 10 percent owner: | 272.8K | 8.55% | Form 4 | Nov 21, 2025 |
| BlackRock, Inc. | 152.5K | 4.78% | 13F | May 13, 2026 |
| Vanguard Capital Management LLC | 111.3K | 3.49% | 13F | May 15, 2026 |
| Richard Lee Jr van Kirk · director, officer: Chief Executive Officer | 99.2K | 3.11% | Form 4 | Jul 6, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Mar 16, 2026 | Angelita Rebamontan Domingo | director | −998 | $47.24 |
| May 22, 2026 | Richard Lee Jr van Kirk | director, officer: Chief Executive Officer | −4,128 | $62.36 |
| May 21, 2026 | Richard Lee Jr van Kirk | director, officer: Chief Executive Officer | −5,872 | $62.81 |
Peers
- CONMED
Powered orthopedic tools and shavers in the same procedure mix
- Stryker
Broad orthopedic power platforms and repair services in shared ORs
- Zimmer Biomet
Orthopedic and CMF power systems with broader procedural breadth
- Johnson & Johnson
Small-bone and trauma power tools across orthopedic and thoracic cases
- Smith & Nephew (ADR)
Arthroscopic shavers and sports-medicine towers in shared resection work
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Pro-Dex | $63.50 | +1.96% | $199.7M | 17.3 | 22.6 | 2.7 | +14.6% |
| CONMED | $49.53 | −1.06% | $1.50B | 27.0 | 11.2 | 1.1 | +0.3% |
| Stryker | $334.18 | +1.06% | $126.77B | 34.3 | 20.6 | 4.9 | +9.4% |
| Zimmer Biomet | $100.91 | −0.00% | $19.52B | 24.6 | 11.5 | 2.3 | +4.8% |
| Johnson & Johnson | $268.40 | +0.13% | $645.95B | 31.1 | 22.4 | 6.6 | +6.6% |
| Smith & Nephew (ADR) | $28.72 | −0.93% | $12.17B | 19.2 | — | 1.9 | +3.7% |
| Median | 27.0 | 16.0 | 2.3 | +4.8% |